• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland Department of Health
    Behavioral Health Administration

    Maryland FDA Tobacco Retailer and Enforcement Program

    ​The Behavioral Health Administration (BHA) has a contractual agreement with the Food and Drug Administration (FDA)  to conduct Undercover Buy, Advertising and labeling, and other directed Inspections on behalf of the FDA of Maryland Licensed Tobacco Retailers to ensure their compliance with the Family Smoking Prevention and Tobacco Control Act. The staff that perform these inspections are/must be FDA Commissioned Officers. The inspections are performed statewide (23 counties and Baltimore City). Inspections completed under this contract are submitted to the FDA for final review and enforcement action.  Violations may lead to Warning letters, Civil Money penalties and other enforcement actions.  Since FDA regulates all tobacco products, including e-cigarettes, hookah tobacco, and cigars, retailers selling tobacco products must comply with all applicable federal laws and regulations.   The BHA Commissioned Officer inspections include inspecting all items in the link below that describes the Retailer Overview of FDA Regulations for Selling Tobacco Products:
    https://www.fda.gov/TobaccoProducts/GuidanceComplianceRegulatoryInformation/Retail/default.htm

    Penalties for Non-Compliant Retailers include:

    Warning Letters

    The FDA issues warning letters to traditional “brick and mortar” retail stores nationwide as well as online retailers and manufacturers​ the first time a tobacco compliance check inspection reveals a violation of the federal tobacco laws and regulations that FDA enforces. Failure to promptly and adequately correct all violations and ensure compliance with all applicable laws and regulations may lead to enforcement actions, including Civil Money Penalties or No-Tobacco-Sale Orders.
     

    Civil Money Penalty Complaints

    A Civil Money Penalty (CMP) Complaint is used to initiate an administrative legal action against a retailer that can result in a monetary penalty, called a Civil Money Penalty.
     
    The Tobacco Control Act provides that the amount of a CMP for violations of the regulations in part 1140 shall not exceed certain amounts, depending on the number of previous violations, the time period in which the violations occurred, and other factors (see section 103(q)(2)(A) of the Tobacco Control Act​ ).

    The current maximum amounts are:

    ​Number of Regulation Violations              CMP Amount

     

    1                                                                    $0 (CTP will send a Warning Letter)

    2 within a 12-month period                         $279

    3 within a 24-month period                         $559

    4 within a 24-month period                         $2,236

    5 within a 36-month period                         $5,591

    6 within a 48-month period                         $11,182


     

    No-Tobacco-Sale Orders to Retailers

    Under the law, the FDA may pursue a No-Tobacco-Sale Order (NTSO) against retailers that have a total of five or more repeated violations of certain restrictions within 36 months. Retailers are prohibited from selling regulated tobacco products at the specified location during the period of the NTSO.
      

    The FDA’s Center for Tobacco Products (CTP)

     

    FDA’s Vision Statement

    To make tobacco-related death and disease part of America’s past, not America’s future and, by doing so; ensure a healthier life for every family.
     
    The FDA Center for Tobacco Products (CTP) is responsible for carrying out the Family Smoking Prevention and Tobacco Control Act, which Congress passed in 2009. This law—commonly called the Tobacco Control Act — gives FDA broad authority to regulate the manufacturing, distribution, and marketing of tobacco products.
     

    Visit the FDA’s Web Site to learn more about whom they are and what they do:

     
    Visit the FDA’s Inspection database to view inspection results 

    ​